Tazlin 4,5mg Powder for solution for injection.
PDF Leaflet Revision Date: 06 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of systemic and local bacterial infections.
Dosage (summary)
Adults: 4.5 g every 8 hours; Neutropenic patients: 4.5 g every 6 hours with aminoglycoside.
Onset of Action / Duration
Onset: Immediate, Duration: Varies by infection.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- Anticoagulants
- Methotrexate
- Nondepolarizing muscle relaxants
- Probenecid
Contraindications
- Hypersensitivity to u03b2-lactams
Common side effects
- Headache
- Diarrhoea
- Nausea
- Vomiting
- Abdominal pain
Counselling Points
- Monitor for allergic reactions
- Avoid mixing with aminoglycosides
- Report severe side effects immediately
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis
- Kounis syndrome
Important Disclaimer
The Tazlin 4,5mg Powder for solution for injection. professional information leaflet below is the property of Oethmaan Biosims and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
